U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Verrucae

MedGen UID:
777120
Concept ID:
C3665596
Disease or Syndrome; Finding
Synonyms: Verruca; Verrucas; Wart; Warts
SNOMED CT: Verruca vulgaris (1296947008); Verruca vulgaris (57019003); Verruca simplex (57019003); Common wart (57019003)
 
HPO: HP:0200043
Monarch Initiative: MONDO:0001209

Definition

Warts, benign growths on the skin or mucous membranes that cause cosmetic problems as well as pain and discomfort. Warts most often occur on the hands, feet, and genital areas. [from HPO]

Conditions with this feature

Immunodeficiency due to ficolin3 deficiency
MedGen UID:
462576
Concept ID:
C3151226
Disease or Syndrome
Individuals with ficolin-3 deficiency have highly variable manifestations and a variable age of symptom onset. Some patients may show increased susceptibility to infection in the perinatal or neonatal period, whereas others may show autoimmune features as adults. Ficolin-3, also known as H-ficolin, can activate the lectin pathway of the complement system; deficiency may thus lead to defects in the complement system (summary by Munthe-Fog et al., 2009 and Michalski et al., 2015). For a discussion of genetic heterogeneity of lectin complement activation pathway defects, see LCAPD1 (614372).
Deafness-lymphedema-leukemia syndrome
MedGen UID:
481294
Concept ID:
C3279664
Disease or Syndrome
Primary lymphedema with myelodysplasia, also known as Emberger syndrome, is a rare disorder characterized by childhood-onset lymphedema of the lower limbs, with lymphoscintigraphy suggestive of lymphatic vessel hypoplasia, and genital lymphatic abnormalities. Myelodysplasia is usually with monosomy 7. Multiple warts, deafness, and minor anomalies (mild hypotelorism, neck webbing, and slender fingers) may also be present (summary by Mansour et al., 2010).
Combined immunodeficiency due to STK4 deficiency
MedGen UID:
766857
Concept ID:
C3553943
Disease or Syndrome
Immunodeficiency-110 (IMD110) is an autosomal recessive primary T-cell immunodeficiency syndrome characterized by progressive loss of naive T cells, recurrent bacterial, viral, and fungal infections, warts, and abscesses, and autoimmune manifestations. Patients are at risk for developing lymphoproliferative disorders or lymphoma, particularly associated with EBV. Some patients may show cardiac malformations, including atrial septal defect (Abdollahpour et al., 2012; Nehme et al., 2012).
Epidermodysplasia verruciformis, susceptibility to, 1
MedGen UID:
1648341
Concept ID:
C4722564
Finding
'Typical' or 'classic' epidermodysplasia verruciformis (EV) is a rare genodermatosis characterized by increased susceptibility to infection with specific human papillomavirus (HPV) genotypes, usually beta-HPV strains, and to the oncogenic potential of some of them, mainly HPV5 and HPV8. Affected individuals develop disseminated flat wart-like and pityriasis versicolor-like cutaneous lesions in childhood or adolescence. The lesions are highly resistant to treatment. About half of patients with EV develop skin cancer, including cutaneous Bowen carcinomas in situ and invasive squamous cell carcinomas, mainly on sun-exposed areas. Individuals with typical or classic EV have no additional immunologic abnormalities (Ramoz et al., 2000; review by Beziat, 2020).
Severe combined immunodeficiency due to CARMIL2 deficiency
MedGen UID:
1648422
Concept ID:
C4748304
Disease or Syndrome
Immunodeficiency-58 is an autosomal recessive primary immunologic disorder characterized by early-onset skin lesions, including eczematous dermatitis, infectious abscesses, and warts, recurrent respiratory infections or allergies, and chronic persistent infections with candida, Molluscum contagiosum, mycobacteria, EBV, bacteria, and viruses. Some patients may have gastrointestinal involvement, including inflammatory bowel disease, EBV+ smooth muscle tumors, and esophagitis. Immunologic analysis shows defective T-cell function with decreased Treg cells and deficient CD3/CD28 costimulation responses in both CD4+ and CD8+ T cells. B-cell function may also be impaired (summary by Wang et al., 2016 and Alazami et al., 2018).
Epidermodysplasia verruciformis, susceptibility to, 3
MedGen UID:
1648390
Concept ID:
C4748876
Finding
Epidermodysplasia verruciformis-3 (EV3) is characterized by onset in childhood or early adulthood of persistent disseminated flat warts and pityriasis versicolor-like lesions of the skin that are induced by cutaneous human papillomaviruses (HPVs) of the beta genus. Some patients develop nonmelanoma skin cancer, particularly on areas of the body exposed to the sun. Patients are otherwise healthy and normally resistant to other microorganisms, including other viruses and skintropic pathogens, and even all other cutaneous and mucosal HPVs (de Jong et al., 2018). For a discussion of genetic heterogeneity of susceptibility to epidermodysplasia verruciformis, see EV1 (226400).
Epidermodysplasia verruciformis, susceptibility to, 5
MedGen UID:
1648489
Concept ID:
C4749043
Finding
Immunodeficiency-130 with HPV-related verrucosis (IMD130) an autosomal recessive form of combined immunodeficiency (CID) characterized mainly by the onset of warts and verrucous or plaque-like skin lesions associated with HPV infection, usually in the first 3 decades of life. There is an increased risk of skin malignancy. Some patients may have other symptoms of immune dysfunction, including mycobacterial, herpes simplex virus (HSV), or fungal infections. Immunologic workup shows T-cell lymphopenia, particularly affecting CD4+ T cells (Horev et al., 2015, Arango-Franco et al., 2024).
Immunodeficiency 70
MedGen UID:
1740270
Concept ID:
C5436501
Disease or Syndrome
Immunodeficiency-70 (IMD70) is an autosomal dominant immunologic disorder characterized by severe cutaneous warts on the hands, feet, and face, suggesting increased susceptibility to human papillomavirus (HPV) infection. Affected individuals may also have recurrent bacterial infections, such as sinusitis, as well as feature of autoinflammation, such as colitis, celiac disease, and retinal vasculitis. Laboratory studies show decreased CD4+ T cells and decreased CD19+ B cells; hypogammaglobulinemia has also been observed (summary by Thaventhiran et al., 2020).
WHIM syndrome 1
MedGen UID:
1778124
Concept ID:
C5542296
Disease or Syndrome
WHIM syndrome-1 (WHIMS1) is an autosomal dominant immunologic disorder characterized by neutropenia, hypogammaglobulinemia, and warts due to human papillomavirus (HPV) infection. Despite the peripheral neutropenia, bone marrow aspirates from affected individuals contain abundant mature myeloid cells, a condition termed myelokathexis. The susceptibility to HPV is disproportionate compared with other immunodeficiency conditions (summary by Hernandez et al., 2003). Heusinkveld et al. (2019) provided a detailed review of the clinical features, proposed pathogenesis, and possible therapeutic treatments of WHIM syndrome. There is significant phenotypic variation among patients, such that some individuals may have an 'incomplete' form of the disorder in which one or more of the classic tetrad features are not present. In general, the WHIMS phenotype comprises a spectrum of manifestations with variable expressivity. The pathogenesis of WHIMS1 is postulated to result from impaired CXCL12 (600835)-induced internalization of CXCR4, resulting in prolonged receptor presence at the cell surface that likely contributes to amplification of signaling with a gain-of-function effect. Genetic Heterogeneity of WHIM Syndrome See also WHIMS2 (619407), caused by mutation in the CXCR2 gene (146928) on chromosome 2q35.
Immunodeficiency 102
MedGen UID:
1812534
Concept ID:
C5676886
Disease or Syndrome
Immunodeficiency-102 (IMD102) is an X-linked recessive immunologic disorder characterized by the onset of recurrent sinopulmonary, mucosal, and other infections in early childhood, usually accompanied by refractory autoimmune cytopenias. Affected individuals have bacterial, viral, and fungal infections, as well as hemolytic anemia, thrombocytopenia, lymphopenia, and decreased NK cells. Laboratory studies show defective T-cell proliferation and function, likely due to signaling abnormalities. The disorder may also manifest as a hyperinflammatory state with immune dysregulation (Delmonte et al., 2021).
Immunodeficiency 115 with autoinflammation
MedGen UID:
1847791
Concept ID:
C5882724
Disease or Syndrome
Immunodeficiency-115 with autoinflammation (IMD115) is an autosomal recessive disorder characterized by the onset of symptoms of immune dysregulation in early infancy. Affected individuals have immunodeficiency with recurrent bacterial, viral, and fungal infections, as well as autoinflammatory features, including arthritis and dermatitis. Some patients may have more systemic involvement, such as myopathy, gastrointestinal abnormalities, and anemia. Laboratory studies show variable B-cell and T-cell defects, sometimes with defective antibody responses and hypogammaglobulinemia (Boisson et al., 2015; Oda et al., 2019).
Neutropenia, severe congenital, 11, autosomal dominant
MedGen UID:
1846394
Concept ID:
C5882742
Disease or Syndrome
Autosomal dominant severe congenital neutropenia-11 (SCN11) is characterized by the onset of recurrent infections, mainly bacterial, in early childhood. Laboratory studies show severe neutropenia due to maturation arrest and impaired development of myeloid cells. Other leukocyte subsets, including B cells and NK cells, may also be subtly affected. Patients should be followed for possible renal dysfunction (Van Nieuwenhove et al., 2020). For discussion of genetic heterogeneity of severe congenital neutropenia, see SCN1 (202700).

Professional guidelines

PubMed

Paasch U, Zidane M, Baron JM, Bund T, Cappius HJ, Drosner M, Feise K, Fischer T, Gauglitz G, Gerber PA, Grunewald S, Herberger K, Jung A, Karsai S, Kautz G, Philipp C, Schädel D, Seitz AT, Nast A
J Dtsch Dermatol Ges 2022 Sep;20(9):1248-1267. Epub 2022 Sep 13 doi: 10.1111/ddg.14879. PMID: 36098675
Witchey DJ, Witchey NB, Roth-Kauffman MM, Kauffman MK
J Am Osteopath Assoc 2018 Feb 1;118(2):92-105. doi: 10.7556/jaoa.2018.024. PMID: 29379975
Vlahovic TC, Khan MT
Clin Podiatr Med Surg 2016 Jul;33(3):337-53. Epub 2016 Mar 29 doi: 10.1016/j.cpm.2016.02.003. PMID: 27215155

Recent clinical studies

Etiology

Hagon W, Hagon J, Noble G, Brenton-Rule A, Stewart S, Bristow I
J Foot Ankle Res 2023 Jun 15;16(1):37. doi: 10.1186/s13047-023-00638-8. PMID: 37322512Free PMC Article
Shimizu A, Yamaguchi R, Kuriyama Y
J Dermatol 2023 Mar;50(3):290-298. Epub 2023 Jan 5 doi: 10.1111/1346-8138.16697. PMID: 36601717
Carmona Lorduy M, Harris Ricardo J, Hernández Arenas Y, Medina Carmona W
Gen Dent 2018 Mar-Apr;66(2):47-49. PMID: 29513235
Witchey DJ, Witchey NB, Roth-Kauffman MM, Kauffman MK
J Am Osteopath Assoc 2018 Feb 1;118(2):92-105. doi: 10.7556/jaoa.2018.024. PMID: 29379975
Vlahovic TC, Spadone S, Dunn SP, Fussell T, Hersh I, Green T, Merrill J, Ghosh P, Tran T
J Am Podiatr Med Assoc 2015 Sep;105(5):395-400. doi: 10.7547/14-062. PMID: 26429607

Diagnosis

Hansen I, Augustin M, Schäfer I, Mohr N
J Dtsch Dermatol Ges 2022 May;20(5):589-595. Epub 2022 Apr 5 doi: 10.1111/ddg.14702. PMID: 35384269
Hood CR Jr, Miller JR
J Am Podiatr Med Assoc 2018 Mar;108(2):189-193. doi: 10.7547/16-115. PMID: 29634299
Witchey DJ, Witchey NB, Roth-Kauffman MM, Kauffman MK
J Am Osteopath Assoc 2018 Feb 1;118(2):92-105. doi: 10.7556/jaoa.2018.024. PMID: 29379975
Vlahovic TC, Khan MT
Clin Podiatr Med Surg 2016 Jul;33(3):337-53. Epub 2016 Mar 29 doi: 10.1016/j.cpm.2016.02.003. PMID: 27215155
Moghaddas N
Clin Podiatr Med Surg 2004 Oct;21(4):651-61, viii. doi: 10.1016/j.cpm.2004.05.007. PMID: 15450904

Therapy

Kaul S, Kaur I, Jakhar D, Edigin E, Caldito EG
Dermatol Ther 2021 Jan;34(1):e14401. Epub 2020 Oct 21 doi: 10.1111/dth.14401. PMID: 33040473
Hood CR Jr, Miller JR
J Am Podiatr Med Assoc 2018 Mar;108(2):189-193. doi: 10.7547/16-115. PMID: 29634299
Witchey DJ, Witchey NB, Roth-Kauffman MM, Kauffman MK
J Am Osteopath Assoc 2018 Feb 1;118(2):92-105. doi: 10.7556/jaoa.2018.024. PMID: 29379975
Wollenberg A
Chem Immunol Allergy 2012;96:89-95. Epub 2012 Mar 13 doi: 10.1159/000331892. PMID: 22433376
Keogh-Brown MR, Fordham RJ, Thomas KS, Bachmann MO, Holland RC, Avery AJ, Armstrong SJ, Chalmers JR, Howe A, Rodgers S, Williams HC, Harvey I
Br J Dermatol 2007 Apr;156(4):687-92. Epub 2007 Feb 27 doi: 10.1111/j.1365-2133.2007.07768.x. PMID: 17326748

Prognosis

Abdelaal MA, Abdelaziz HM, Ahmed KA, Elsaie ML
J Drugs Dermatol 2021 May 1;20(5):546-549. doi: 10.36849/JDD.5264. PMID: 33938709
Dardet JP, Blasingame NP, Okpare D, Leffler L, Barbosa P
Clin Podiatr Med Surg 2020 Apr;37(2):317-325. Epub 2020 Feb 5 doi: 10.1016/j.cpm.2019.12.010. PMID: 32146987
Dobson JS, Harland CC
Lasers Surg Med 2014 Feb;46(2):112-6. Epub 2013 Nov 20 doi: 10.1002/lsm.22199. PMID: 24258968
Ljubojević S, Lipozencić J, Grgec DL, Prstacić R, Skerlev M, Mokos ZB
Coll Antropol 2008 Sep;32(3):989-97. PMID: 18982779
Stern P, Levine N
Arch Dermatol 1992 Jul;128(7):945-8. PMID: 1626962

Clinical prediction guides

Abdelaal MA, Abdelaziz HM, Ahmed KA, Elsaie ML
J Drugs Dermatol 2021 May 1;20(5):546-549. doi: 10.36849/JDD.5264. PMID: 33938709
Witchey DJ, Witchey NB, Roth-Kauffman MM, Kauffman MK
J Am Osteopath Assoc 2018 Feb 1;118(2):92-105. doi: 10.7556/jaoa.2018.024. PMID: 29379975
Clouth A, Schöfer H
J Eur Acad Dermatol Venereol 2015 Jan;29(1):178-9. Epub 2013 Dec 17 doi: 10.1111/jdv.12341. PMID: 24341392
Abess A, Keel DM, Graham BS
Arch Dermatol 2003 Mar;139(3):337-9. doi: 10.1001/archderm.139.3.337. PMID: 12622626
Rübben A, Kalka K, Spelten B, Grussendorf-Conen EI
Arch Dermatol Res 1997 May;289(6):337-40. doi: 10.1007/s004030050201. PMID: 9209679

Recent systematic reviews

Le M, Conte S, Hsu JTS, Li MK
Dermatol Surg 2024 Apr 1;50(4):345-353. doi: 10.1097/DSS.0000000000004069. PMID: 38551277
Hansen I, Augustin M, Schäfer I, Mohr N
J Dtsch Dermatol Ges 2022 May;20(5):589-595. Epub 2022 Apr 5 doi: 10.1111/ddg.14702. PMID: 35384269
Maranda EL, Lim VM, Nguyen AH, Nouri K
J Eur Acad Dermatol Venereol 2016 Oct;30(10):1700-1707. Epub 2016 Jun 29 doi: 10.1111/jdv.13789. PMID: 27356496
Nguyen J, Korta DZ, Chapman LW, Kelly KM
JAMA Dermatol 2016 Sep 1;152(9):1025-34. doi: 10.1001/jamadermatol.2016.0826. PMID: 27119270
Keogh-Brown MR, Fordham RJ, Thomas KS, Bachmann MO, Holland RC, Avery AJ, Armstrong SJ, Chalmers JR, Howe A, Rodgers S, Williams HC, Harvey I
Br J Dermatol 2007 Apr;156(4):687-92. Epub 2007 Feb 27 doi: 10.1111/j.1365-2133.2007.07768.x. PMID: 17326748

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Consumer resources

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...